Lyell Immunopharma (LYEL) Treasury Shares (2020 - 2026)

Lyell Immunopharma (LYEL) has 7 years of Treasury Shares data on file, last reported at $36398.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 99.6% year-over-year to $36398.0; the trailing twelve-month figure through Mar 2026 stood at $36398.0 (down 99.6% YoY), and the FY2025 full-year result was $306415.0, up 126.69% from the prior year.
• Treasury Shares retreated to $36398.0 in Q1 2026, from $306415.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $9.1 million in Q1 2025 to a low of $36398.0 in Q1 2026.
• A 5-year average of $2.2 million and a median of $1.4 million in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares jumped 236.81% in 2025 and tumbled 99.6% in 2026, its largest moves.
• Tracing LYEL's Treasury Shares over 5 years: stood at $872077.0 in 2022, then jumped by 218.44% to $2.8 million in 2023, then plunged by 95.13% to $135170.0 in 2024, then surged by 126.69% to $306415.0 in 2025, then plunged by 88.12% to $36398.0 in 2026.
• Business Quant data shows LYEL's Treasury Shares at $36398.0 in Q1 2026, $306415.0 in Q4 2025, and $84047.0 in Q3 2025.